Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Encompass Health Corporation EHC
$61.16
-$0.72 (-1.17%)
На 18:00, 12 мая 2023
+44.29%
Потенциал через год
Ранг: 1
Ключевые показатели
-
Marketcap
6173535240.00000000
-
week52high
66.44
-
week52low
42.19
-
Revenue
4348600000
-
P/E TTM
19
-
Beta
0.95605500
-
EPS
2.57000000
-
Last Dividend
0.60000000
-
Next Earnings Date
31 июл 2023 г. в 10:59
Описание компании
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| RBC Capital | Outperform | Outperform | 24 авг 2022 г. |
| Truist Securities | Buy | Buy | 08 авг 2022 г. |
| Raymond James | Strong Buy | Strong Buy | 04 авг 2022 г. |
| BMO Capital | Outperform | Outperform | 04 авг 2022 г. |
| Barclays | Overweight | Overweight | 04 авг 2022 г. |
| Credit Suisse | Outperform | Outperform | 21 сент 2022 г. |
| Stephens & Co. | Overweight | Overweight | 28 окт 2022 г. |
| Raymond James | Strong Buy | Strong Buy | 28 окт 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Williams Terrance | A | 9092 | 22 | 17 янв 2023 г. |
| CORRELL DONALD L | A | 96479 | 233 | 17 янв 2023 г. |
| SCHLICHTING NANCY M | A | 15038 | 37 | 17 янв 2023 г. |
| CARMICHAEL GREG D | A | 10568 | 22 | 17 янв 2023 г. |
| Maryland Patricia Anne | A | 8738 | 22 | 17 янв 2023 г. |
| Reidy Christopher R | A | 6096 | 11 | 17 янв 2023 г. |
| Reidy Christopher R | A | 6101 | 5 | 17 янв 2023 г. |
| KATZ LESLYE G | A | 41032 | 99 | 17 янв 2023 г. |
| O'Connor Kevin J. | A | 3969 | 8 | 17 янв 2023 г. |
| CHIDSEY JOHN | A | 157007 | 682 | 17 янв 2023 г. |
Новостная лента
Encompass Health: Rotating Capital Investments Into Market Valuation
Seeking Alpha
11 мая 2023 г. в 17:45
Encompass Health Corporation continues to deliver in 2023, with investors rating its market valuation higher after Q1 FY'23 earnings. The company's financial performance is matched by a deeper set of drivers underneath the hood.
Encompass Health's (EHC) Q1 Earnings Beat, '23 EPS View Up
Zacks Investment Research
03 мая 2023 г. в 14:27
Encompass Health's (EHC) Q1 results reflect improved patient volumes and higher discharge growth. Management estimates 2023 adjusted EPS within $2.94-$3.23, up from the earlier view of $2.87-$3.16.
Encompass Health Corporation (EHC) Q1 2023 Results - Earnings Call Transcript
Seeking Alpha
28 апр 2023 г. в 16:22
Encompass Health Corporation (NYSE:EHC ) Q1 2023 Earnings Conference Call April 28, 2023 10:00 AM ET Company Participants Mark Miller - IR Mark Tarr - President & CEO Doug Coltharp - CFO Conference Call Participants Kevin Fischbeck - Bank of America A.J. Rice - Credit Suisse Pito Chickering - Deutsche Bank Andrew Mok - UBS Ben Hendrix - RBC Capital Markets Brian Tanquilut - Jefferies Ann Hynes - Mizuho Securities Operator Good morning, everyone, and welcome to Encompass Health's First Quarter 2023 Earnings Conference Call.
Encompass Health (EHC) Q1 Earnings and Revenues Surpass Estimates
Zacks Investment Research
27 апр 2023 г. в 20:29
Encompass Health (EHC) came out with quarterly earnings of $0.88 per share, beating the Zacks Consensus Estimate of $0.70 per share. This compares to earnings of $0.97 per share a year ago.
Are Investors Undervaluing Encompass Health (EHC) Right Now?
Zacks Investment Research
21 апр 2023 г. в 11:25
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.